FROM 2007 to 2016, the US Food and Drug Administration (FDA) approved more new drugs and biologics first than its European and Swiss regulatory counterparts, according to a comparison in the European Journal of Clinical Pharmacology - CLICK HERE.
PEOPLE with obesity who take glucagon-like peptide-1 receptor agonists (GLP-1RAs) have a reduced risk of cancer compared to those not using those medications, according to US research published today in JAMA Oncology.
PHARMACISTS from across Australia recently came together for the Pharmacy Snow Business Conference at Mt Buller, sharing a passion for skiing alongside their commitment to professional development.
PHARMX Technologies yesterday announced strong results for the financial year ending 30 Jun 2025, with total revenues of $7.5 million, up 13% on the previous corresponding period.
Notifications
